COSENTYX
COSENTYX
Approved
DIN Number
02525569
Drug Class
Human
Market Date
Jun 2, 2022
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02525569
AIG Number0156650001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AC10 SECUKINUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
SECUKINUMABActive
Strength: 75 MG / 0.5 ML
Monograph: SECUKINUMAB